Clinical Trial Update: Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET) [Phase 4]

View source ↗

Summary

Phase 4 trial assessing dopamine transporter occupancy of toludesvenlafaxine hydrochloride extended-release in patients with major depressive disorder using PET…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Toludesvenlafaxine hydrochloride extended-release tablets (toludesvenlafaxine hydrochloride)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Major Depressive Disorder | Phase 4 | Status: UNKNOWN